Cargando…

Immunotherapeutic approaches for hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a cancer with a high mortality rate due to the fact that the diagnosis usually occurs at anadvanced stage. Even in case of curative surgical treatment, recurrence is common. Sorafenib and regorafenib are the only therapeutic agents that have been demonstrated to be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Longo, Vito, Gnoni, Antonio, Gardini, Andrea Casadei, Pisconti, Salvatore, Licchetta, Antonella, Scartozzi, Mario, Memeo, Riccardo, Palmieri, Vincenzo Ostilio, Aprile, Giuseppe, Santini, Daniele, Nardulli, Patrizia, Silvestris, Nicola, Brunetti, Oronzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464921/ https://www.ncbi.nlm.nih.gov/pubmed/28420805 http://dx.doi.org/10.18632/oncotarget.15406

Ejemplares similares

Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies
por: Gnoni, Antonio, et al.
Publicado: (2019)

Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
por: Longo, Vito, et al.
Publicado: (2019)

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
por: Brunetti, Oronzo, et al.
Publicado: (2019)

Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions
por: Gnoni, Antonio, et al.
Publicado: (2013)

Immune system and bone microenvironment: rationale for targeted cancer therapies
por: Gnoni, Antonio, et al.
Publicado: (2020)

Strategies to Improve Cancer Immune Checkpoint Inhibitors Efficacy, Other Than Abscopal Effect: A Systematic Review
por: Longo, Vito, et al.
Publicado: (2019)

Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue
por: Longo, Vito, et al.
Publicado: (2016)

Antiangiogenic agents after first line and sorafenib plus chemoembolization: a systematic review
por: Gardini, Andrea Casadei, et al.
Publicado: (2017)

The correlation between LDH serum levels and clinical outcome in advanced biliary tract cancer patients treated with first line chemotherapy
por: Faloppi, Luca, et al.
Publicado: (2016)

Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study
por: Casadei Gardini, Andrea, et al.
Publicado: (2017)

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
por: Brunetti, Oronzo, et al.
Publicado: (2015)

Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy
por: Casadei-Gardini, Andrea, et al.
Publicado: (2023)

Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy
por: Fasano, Rossella, et al.
Publicado: (2021)

Natural History of Malignant Bone Disease in Hepatocellular Carcinoma: Final Results of a Multicenter Bone Metastasis Survey
por: Santini, Daniele, et al.
Publicado: (2014)

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New
por: Faloppi, Luca, et al.
Publicado: (2016)

Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer
por: Lafranceschina, Stefano, et al.
Publicado: (2019)

Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview
por: Argentiero, Antonella, et al.
Publicado: (2019)

Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
por: Argentiero, Antonella, et al.
Publicado: (2020)

Angiogenesis in adenosquamous cancer of pancreas
por: Silvestris, Nicola, et al.
Publicado: (2017)

Immune inflammation indicators and implication for immune modulation strategies in advanced hepatocellular carcinoma patients receiving sorafenib
por: Gardini, Andrea Casadei, et al.
Publicado: (2016)

Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen
por: Perri, Francesco, et al.
Publicado: (2015)

COVID Vaccination in Cancer Patients: What Vaccination Priority Strategies Should There Be?
por: Silvestris, Nicola, et al.
Publicado: (2021)

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
por: Hosseinkhani, Negar, et al.
Publicado: (2021)

Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era
por: Burgaletto, Chiara, et al.
Publicado: (2021)

Incidental Echocardiographic Finding of a Membranous Ventricular Septal Aneurysm in an 18-Year-Old Asymptomatic Athlete
por: Giovannetti, Guido, et al.
Publicado: (2022)

NLRP3 Inflammasome From Bench to Bedside: New Perspectives for Triple Negative Breast Cancer
por: Sonnessa, Margherita, et al.
Publicado: (2020)

Immunotherapeutic Intervention against Sarcomas
por: Pedrazzoli, Paolo, et al.
Publicado: (2011)

Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN)
por: Pedrazzoli, Paolo, et al.
Publicado: (2017)

Editorial: The Effect of the COVID-19 Pandemic on Cancer Patients and Healthcare
por: Silvestris, Nicola, et al.
Publicado: (2022)

Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis
por: Solimando, Antonio Giovanni, et al.
Publicado: (2021)

Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
por: Kooshkaki, Omid, et al.
Publicado: (2020)

Cognitive Efficiency and Fitness-to-Drive along the Lifespan: The Mediation Effect of Visuospatial Transformations
por: Tinella, Luigi, et al.
Publicado: (2021)

What These Findings Tell Us. Reply to Kelly et al. What Do These Findings Tell Us? Comment on “Tinella et al. Cognitive Efficiency and Fitness-to-Drive along the Lifespan: The Mediation Effect of Visuospatial Transformations. Brain Sci. 2021, 11, 1028”
por: Tinella, Luigi, et al.
Publicado: (2022)

Reassessing Fitness-to-Drive in Drinker Drivers: The Role of Cognition and Personality
por: Tinella, Luigi, et al.
Publicado: (2021)

Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
por: Paradiso, Angelo Virgilio, et al.
Publicado: (2020)

Potential predictive role of chemotherapy-induced changes of soluble CD40 ligand in untreated advanced pancreatic ductal adenocarcinoma
por: Azzariti, Amalia, et al.
Publicado: (2016)

Molecular Characterization of a Long-Term Survivor Double Metastatic Non-Small Cell Lung Cancer and Pancreatic Ductal Adenocarcinoma Treated with Gefitinib in Combination with Gemcitabine Plus Nab-Paclitaxel and mFOLFOX6 as First and Second Line Therapy
por: Brunetti, Oronzo, et al.
Publicado: (2019)

A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021)

On the Management of Drug Interactions in the Course of Concomitant Treatments for COVID-19 and Antineoplastic Agents
por: Silvestris, Nicola, et al.
Publicado: (2020)

COVID-19 Infection in Cancer Patients: How Can Oncologists Deal With These Patients?
por: Brunetti, Oronzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bklq67dkt8kv2jppd9q2kj7p81